Literature DB >> 18402509

Parkinson's disease--Part 3: Neuropsychiatric symptoms.

Daniel Weintraub1, Cynthia L Comella, Stacy Horn.   

Abstract

The nonmotor neuropsychiatric symptoms of Parkinson's disease, particularly depression, psychosis, and cognitive impairment/dementia, are major contributors to disability and a decline in quality of life. Their effect on patients may be more disabling than motor symptoms. Increasing awareness of the importance of recognizing and treating neuropsychiatric symptoms of this disease in the medical community is a focus of specialists and organizations. This article looks at useful screening measures to help clinicians recognize neuropsychiatric symptoms and offers suggestions for their effective treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18402509

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  17 in total

Review 1.  Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Authors:  Teri R Thomsen; Robert L Rodnitzky
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

Review 2.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

Review 3.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

4.  Human adipose-derived mesenchymal stem cells improve motor functions and are neuroprotective in the 6-hydroxydopamine-rat model for Parkinson's disease when cultured in monolayer cultures but suppress hippocampal neurogenesis and hippocampal memory function when cultured in spheroids.

Authors:  Jürgen Berg; Manfred Roch; Jennifer Altschüler; Christine Winter; Anne Schwerk; Andreas Kurtz; Barbara Steiner
Journal:  Stem Cell Rev Rep       Date:  2015-02       Impact factor: 5.739

5.  The ethics of sham surgery on research subjects with cognitive impairments that affect decision-making capacity.

Authors:  David B Resnik; Frank Miller
Journal:  Contemp Clin Trials       Date:  2010-06-04       Impact factor: 2.226

Review 6.  Animal models of the non-motor features of Parkinson's disease.

Authors:  Kimberly McDowell; Marie-Françoise Chesselet
Journal:  Neurobiol Dis       Date:  2012-01-03       Impact factor: 5.996

7.  Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine.

Authors:  Katsuaki Suzuki; Kyoko Okada; Tomoyasu Wakuda; Chie Shinmura; Yosuke Kameno; Keiko Iwata; Taro Takahashi; Shiro Suda; Hideo Matsuzaki; Yasuhide Iwata; Kenji Hashimoto; Norio Mori
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

8.  Health-related quality of life and alternative forms of exercise in Parkinson disease.

Authors:  Madeleine E Hackney; Gammon M Earhart
Journal:  Parkinsonism Relat Disord       Date:  2009-03-28       Impact factor: 4.891

9.  The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases.

Authors:  D K Lahiri; B Maloney; N H Zawia
Journal:  Mol Psychiatry       Date:  2009-11       Impact factor: 15.992

10.  The influence of facial masking and sex on older adults' impressions of individuals with Parkinson's disease.

Authors:  Amanda R Hemmesch; Linda Tickle-Degnen; Leslie A Zebrowitz
Journal:  Psychol Aging       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.